These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 8378140

  • 1. [Plain MR imaging of breast lesions: a study using 3 mm slice thickness].
    Kumagai H, Ito H, Hashimoto S.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Jul 25; 53(7):801-5. PubMed ID: 8378140
    [Abstract] [Full Text] [Related]

  • 2. Markedly high signal intensity lesions in the uterine cervix on T2-weighted imaging: differentiation between mucin-producing carcinomas and nabothian cysts.
    Li H, Sugimura K, Okizuka H, Yoshida M, Maruyama R, Takahashi K, Miyazaki K.
    Radiat Med; 1999 Jul 25; 17(2):137-43. PubMed ID: 10399782
    [Abstract] [Full Text] [Related]

  • 3. [MR tomographic characterization of suspicious breast lesions with dynamic susceptibility-weighted T2* sequences].
    Dannert S, Krück W, Schick F, Claussen CD, Müller-Schimpfle M.
    Rofo; 2001 Jan 25; 173(1):38-43. PubMed ID: 11225415
    [Abstract] [Full Text] [Related]

  • 4. Magnetic resonance imaging of thymic epithelial tumors.
    Kushihashi T, Fujisawa H, Munechika H.
    Crit Rev Diagn Imaging; 1996 Aug 25; 37(3):191-259. PubMed ID: 8872410
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of strongly hyperintense area in breast lesions on fat-suppressed T2-weighted images correlated with histopathology].
    Isomoto I, Koshiishi T, Okimoto T, Ishimaru K, Abe K, Uetani M, Hayashi K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 2004 Mar 25; 64(3):99-106. PubMed ID: 15148784
    [Abstract] [Full Text] [Related]

  • 6. Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis.
    Yuen S, Uematsu T, Kasami M, Tanaka K, Kimura K, Sanuki J, Uchida Y, Furukawa H.
    J Magn Reson Imaging; 2007 Mar 25; 25(3):502-10. PubMed ID: 17326093
    [Abstract] [Full Text] [Related]

  • 7. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F, Castrucci M, Sironi S, Livraghi T, Venturini M, Salvioni M, Del Maschio A.
    Radiol Med; 1994 Dec 25; 88(6):806-17. PubMed ID: 7878241
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
    Maurea S, Imbriaco M, D'Angelillo M, Mollica C, Camera L, Salvatore M.
    Radiol Med; 2006 Aug 25; 111(5):674-86. PubMed ID: 16791464
    [Abstract] [Full Text] [Related]

  • 9. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
    Kuhl CK, Kreft BP, Hauswirth A, Gieseke J, Elevelt A, Reiser M, Schild HH.
    Rofo; 1995 Jun 25; 162(6):482-91. PubMed ID: 7605960
    [Abstract] [Full Text] [Related]

  • 10. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G, Topal U.
    Eur J Radiol; 2006 Mar 25; 57(3):436-44. PubMed ID: 16316732
    [Abstract] [Full Text] [Related]

  • 11. [Role of MR imaging in the differentiation of benign and nonbenign intracranial meningiomas: the utility of contrast-enhanced T1-weighted images].
    Tanaka Y, Matsuo M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jan 25; 56(1):1-8. PubMed ID: 8857091
    [Abstract] [Full Text] [Related]

  • 12. Application of a mixed imaging sequence for MR imaging characterization of human breast disease.
    Merchant TE, Thelissen GR, de Graaf PW, Nieuwenhuizen CW, Kievit HC, Den Otter W.
    Acta Radiol; 1993 Jul 25; 34(4):356-61. PubMed ID: 8318297
    [Abstract] [Full Text] [Related]

  • 13. [MR characterization of breast pathology using inversion recovery sequence].
    Testa A, Patrizio G, Beomonte Zobel B, Masciocchi C, Gallucci M, Cardone G, Ciccozzi A, Ventura T, Passariello R.
    Radiol Med; 1989 Oct 25; 78(4):329-34. PubMed ID: 2595025
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Differentiation of bronchogenic carcinoma from benign nodule by MR imaging: quantitative evaluation].
    Kuriyama K, Kadota T, Hosomi N, Sawai Y, Inoue E, Narumi Y, Fujita M, Yoshioka H, Kuroda C.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Jun 25; 53(6):628-34. PubMed ID: 8337104
    [Abstract] [Full Text] [Related]

  • 19. Can MR Imaging contribute in characterizing well-circumscribed breast carcinomas?
    Yoo JL, Woo OH, Kim YK, Cho KR, Yong HS, Seo BK, Kim A, Kang EY.
    Radiographics; 2010 Oct 25; 30(6):1689-702. PubMed ID: 21071383
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.